Pharmaceutical Quality (Industry), published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/uv-dx-pq/ and changes regularly. See the Directory of published versions
Active as of 2024-05-08 |
Generated Narrative: PlanDefinition
Resource PlanDefinition "plandefinition-drug-pq-ex5-stability-study-protocol"
Profile: PlanDefinition - Drug PQ
url: http://example-server.com/fhir/PlanDefinition/plandefinition-drug-pq-ex5-stability-study-protocol
identifier: URI/urn:oid:2.16.840.1.113883.4.642.40.41.34.5
version: 1.0.0
title: Stability Monitoring Program
type: Stability Study Protocol (Pharmaceutical Plan Type Codes#1244588)
status: active
subject: MedicinalProductDefinition/medicinalproductdefinition-drug-product-pq-ex1
date: 2024-05-08 12:53:57+0000
publisher: HL7 International / Biomedical Research and Regulation
contact: HL7 International - Biomedical Research and Regulation: http://www.hl7.org/Special/committees/rcrim
description: Narrative description of Stability Study
jurisdiction: World (m49.htm#001)
action
title: Stability Test Protocol for Long-term and Accelerated Storage of Stelbat Tablets, 20 mg
action
title: Long-Term
description: 25°C/60% RH
action